https://scholars.lib.ntu.edu.tw/handle/123456789/507741
標題: | Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures | 作者: | Huang, C.-C. Tu, S.-H. Lien, H.-H. Huang, C.-S. Huang, C.-J. LIANG-CHUAN LAI Tsai, M.-H. MONG-HSUN TSAI ERIC YAO-YU CHUANG |
公開日期: | 2014 | 出版社: | Springer New York LLC | 卷: | 147 | 期: | 2 | 起(迄)頁: | 353-370 | 來源出版物: | Breast Cancer Research and Treatment | 摘要: | Several prognostic signatures have been identified for breast cancer. However, these signatures vary extensively in their gene compositions, and the poor concordance of the risk groups defined by the prognostic signatures hinders their clinical applicability. Breast cancer risk prediction was refined with a novel approach to finding concordant genes from leading edge analysis of prognostic signatures. Each signature was split into two gene sets, which contained either up-regulated or down-regulated genes, and leading edge analysis was performed within each array study for all up-/down-regulated gene sets of the same signature from all training datasets. Consensus of leading edge subsets among all training microarrays was used to synthesize a predictive model, which was then tested in independent studies by partial least squares regression. Only a small portion of six prognostic signatures (Amsterdam, Rotterdam, Genomic Grade Index, Recurrence Score, and Hu306 and PAM50 of intrinsic subtypes) was significantly enriched in the leading edge analysis in five training datasets (n?=?2,380), and that the concordant leading edge subsets (43 genes) could identify the core signature genes that account for the enrichment signals providing prognostic power across all assayed samples. The proposed concordant leading edge algorithm was able to discriminate high-risk from low-risk patients in terms of relapse-free or distant metastasis-free survival in all training samples (hazard ratios: 1.84–2.20) and in three out of four independent studies (hazard ratios: 3.91–8.31). In some studies, the concordant leading edge subset remained a significant prognostic factor independent of clinical ER, HER2, and lymph node status. The present study provides a statistical framework for identifying core consensus across microarray studies with leading edge analysis, and a breast cancer risk predictive model was established. ? 2014, Springer Science+Business Media New York. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027957781&doi=10.1007%2fs10549-014-3104-6&partnerID=40&md5=6291ba03dcfa3022da05d0ab3e3ae397 https://scholars.lib.ntu.edu.tw/handle/123456789/507741 |
ISSN: | 0167-6806 | DOI: | 10.1007/s10549-014-3104-6 | SDG/關鍵字: | Article; breast cancer; cancer prognosis; cancer risk; down regulation; gene expression; gene sequence; gene signature; genetic analysis; human; leading edge analysis; microarray analysis; priority journal; risk assessment; upregulation |
顯示於: | 生理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。